Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
-
Early trial tests cell injection to repair diabetic kidneys
Disease control Recruiting nowThis early-stage study is testing the safety of an experimental cell therapy called REGEND003 in people with type 2 diabetes and chronic kidney disease. The therapy involves injecting human kidney progenitor cells directly into the kidney, with the goal of repairing kidney damage…
Phase: PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 03:42 UTC
-
First-of-its-Kind stem cell trial offers hope for kids with rare lung damage
Disease control Recruiting nowThis early-stage study is testing whether a patient's own airway stem cells can help treat children with bronchiolitis obliterans, a rare and serious lung disease that often follows a severe infection. Researchers will give 12 children a single treatment and closely monitor their…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC